Position in EOLS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,041,000
New position
Shares Held
150,000
first reported quarter
Ownership
0.227%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#40
of 157 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KVP Capital Advisors, LP holds $3,614,692 across 2 Drug Manufacturers - Specialty & Generic names. EOLS ranks #2 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,750 | $2,573,692 | |
| 2 | EOLS |
Evolus, Inc.
This page
|
150,000 | $1,041,000 |
All Filings in EOLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,041,000 | 150,000 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||